EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Effect of Oral Zinc Supplementation on Serum Bilirubin Levels in Term Neonates with Hyperbilirubinemia: A Randomized Controlled Trial

Sanjay Meena, Ritu Bijarnia, Kannupriya Choudhary, Sandeep Choudhary

Indian Journal of Medical Specialities · 2026-07 · 17 (3) · 213-217

DOI: 10.4103/injms.injms_2_26 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Indian Journal of Medical Specialities, online erschienen am 06.07.2026. Verfasst von Sanjay Meena und 3 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neonatal hyperbilirubinemia is a common condition in the early neonatal period and, if severe, may result in bilirubin-induced neurological dysfunction. Phototherapy is the standard treatment; however, prolonged therapy is associated with increased hospital stay and potential adverse effects. Zinc has been proposed as an adjunct therapy due to its ability to inhibit enterohepatic circulation of bilirubin.

Objectives

To evaluate the effect of oral zinc supplementation in reduction of serum bilirubin levels in term neonates undergoing phototherapy and to compare the duration of phototherapy and hospital stay between zinc-supplemented and placebo groups. Materials and Methods: This randomized controlled trial was conducted in the Department of Paediatrics, Dr. S. N. Medical College, Jodhpur, from March to May 2025. A total of 100 term neonates with hyperbilirubinemia requiring phototherapy were randomized into two groups: zinc group ( n = 50) receiving 5 mg oral zinc sulfate daily and placebo group ( n = 50) receiving 5% dextrose, alongside standard phototherapy. Serum bilirubin levels were measured at baseline, 24, 48, and 72 h. Duration of phototherapy and hospital stay were recorded. Statistical analysis was performed using SPSS version 22.

Results

Baseline characteristics were comparable between the groups. The zinc group showed significantly greater reductions in serum bilirubin levels at 24, 48, and 72 h compared to the placebo group ( P < 0.001). Mean duration of phototherapy (47.7 ± 6.4 vs. 59.6 ± 6.4 h) and hospital stay (2.9 ± 0.4 vs. 3.5 ± 0.6 days) were significantly shorter in the zinc group ( P < 0.001).

Conclusion

Oral zinc supplementation is a safe and effective adjunct to phototherapy in term neonates, resulting in faster bilirubin reduction and decreased treatment duration.

Zitieren

APA

Meena, S., Bijarnia, R., Choudhary, K., & Choudhary, S. (2026). Effect of Oral Zinc Supplementation on Serum Bilirubin Levels in Term Neonates with Hyperbilirubinemia: A Randomized Controlled Trial. Indian Journal of Medical Specialities, 17(3), 213-217. https://doi.org/10.4103/injms.injms_2_26

Vancouver

Meena S, Bijarnia R, Choudhary K, Choudhary S. Effect of Oral Zinc Supplementation on Serum Bilirubin Levels in Term Neonates with Hyperbilirubinemia: A Randomized Controlled Trial. Indian Journal of Medical Specialities. 2026;17(3):213-217. doi:10.4103/injms.injms_2_26

BibTeX
@article{Meena2026,
  author = {Meena, Sanjay and Bijarnia, Ritu and Choudhary, Kannupriya and Choudhary, Sandeep},
  title = {Effect of Oral Zinc Supplementation on Serum Bilirubin Levels in Term Neonates with Hyperbilirubinemia: A Randomized Controlled Trial},
  journal = {Indian Journal of Medical Specialities},
  year = {2026},
  volume = {17},
  number = {3},
  pages = {213--217},
  doi = {10.4103/injms.injms_2_26}
}
Kostenlos starten →